225 related articles for article (PubMed ID: 9070498)
1. Descriptive epidemiology of cerebral gliomas in France.
Fleury A; Menegoz F; Grosclaude P; Daures JP; Henry-Amar M; Raverdy N; Schaffer P; Poisson M; Delattre JY
Cancer; 1997 Mar; 79(6):1195-202. PubMed ID: 9070498
[TBL] [Abstract][Full Text] [Related]
2. Trends in incidence of primary brain tumors in the United States, 1985-1994.
Jukich PJ; McCarthy BJ; Surawicz TS; Freels S; Davis FG
Neuro Oncol; 2001 Jul; 3(3):141-51. PubMed ID: 11465394
[TBL] [Abstract][Full Text] [Related]
3. Changing incidence and improved survival of gliomas.
Ho VK; Reijneveld JC; Enting RH; Bienfait HP; Robe P; Baumert BG; Visser O;
Eur J Cancer; 2014 Sep; 50(13):2309-18. PubMed ID: 24972545
[TBL] [Abstract][Full Text] [Related]
4. Intracranial gliomas in Ferrara, Italy, 1976 to 1991.
Tola MR; Casetta I; Granieri E; Pinna L; Veronesi V; Tamarozzi R; Trapella G; Monetti VC; Paolino E; Govoni V
Acta Neurol Scand; 1994 Nov; 90(5):312-7. PubMed ID: 7887130
[TBL] [Abstract][Full Text] [Related]
5. Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006.
Zada G; Bond AE; Wang YP; Giannotta SL; Deapen D
World Neurosurg; 2012; 77(3-4):518-24. PubMed ID: 22120376
[TBL] [Abstract][Full Text] [Related]
6. Time trends in oligodendroglial and astrocytic tumor incidence.
McCarthy BJ; Propp JM; Davis FG; Burger PC
Neuroepidemiology; 2008; 30(1):34-44. PubMed ID: 18259099
[TBL] [Abstract][Full Text] [Related]
7. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.
Deorah S; Lynch CF; Sibenaller ZA; Ryken TC
Neurosurg Focus; 2006 Apr; 20(4):E1. PubMed ID: 16709014
[TBL] [Abstract][Full Text] [Related]
8. [Occurrence and molecular pathology of high grade gliomas].
Murnyák B; Csonka T; Hegyi K; Méhes G; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):312-21. PubMed ID: 24358686
[TBL] [Abstract][Full Text] [Related]
9. The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly.
Werner MH; Phuphanich S; Lyman GH
Cancer; 1995 Nov; 76(9):1634-42. PubMed ID: 8635069
[TBL] [Abstract][Full Text] [Related]
10. [Occurrence and molecular pathology of low grade gliomas].
Murnyák B; Csonka T; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992: a population-based study of pediatric brain tumors.
Hjalmars U; Kulldorff M; Wahlqvist Y; Lannering B
Cancer; 1999 May; 85(9):2077-90. PubMed ID: 10223251
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological findings and five year survival rates for patients with central nervous system tumors in Yazd, Iran.
Zahir ST; Vakili M; Navabii H; Rahmani K
Asian Pac J Cancer Prev; 2014; 15(23):10319-23. PubMed ID: 25556468
[TBL] [Abstract][Full Text] [Related]
13. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
Ohgaki H; Kleihues P
J Neuropathol Exp Neurol; 2005 Jun; 64(6):479-89. PubMed ID: 15977639
[TBL] [Abstract][Full Text] [Related]
14. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
Okamoto Y; Di Patre PL; Burkhard C; Horstmann S; Jourde B; Fahey M; Schüler D; Probst-Hensch NM; Yasargil MG; Yonekawa Y; Lütolf UM; Kleihues P; Ohgaki H
Acta Neuropathol; 2004 Jul; 108(1):49-56. PubMed ID: 15118874
[TBL] [Abstract][Full Text] [Related]
15. Supratentorial gliomas: a comparative study by grade and histologic type.
Shaw EG; Scheithauer BW; O'Fallon JR
J Neurooncol; 1997 Feb; 31(3):273-8. PubMed ID: 9049856
[TBL] [Abstract][Full Text] [Related]
16. Age curves of central nervous system tumor incidence in adults: variation of shape by histologic type.
Velema JP; Percy CL
J Natl Cancer Inst; 1987 Oct; 79(4):623-9. PubMed ID: 3477657
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature.
Chaichana KL; McGirt MJ; Niranjan A; Olivi A; Burger PC; Quinones-Hinojosa A
Neurol Res; 2009 Nov; 31(9):931-9. PubMed ID: 19215664
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. Incidence trends of adult malignant brain tumors in Finland, 1990-2016.
Natukka T; Raitanen J; Haapasalo H; Auvinen A
Acta Oncol; 2019 Jul; 58(7):990-996. PubMed ID: 30985227
[No Abstract] [Full Text] [Related]
20. The trends in incidence of primary brain tumors in the population of Rochester, Minnesota.
Radhakrishnan K; Mokri B; Parisi JE; O'Fallon WM; Sunku J; Kurland LT
Ann Neurol; 1995 Jan; 37(1):67-73. PubMed ID: 7818260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
